Finasteride treatment of female pattern hair loss

Archives of Dermatology

Volumn 142, Issue 3, 2006, Pages 298-302

  Iorizzo, Matilde ^a   Vincenzi, Colombina ^a   Voudouris, Stylianos ^a   Piraccini, Bianca Maria ^a   Tosti, Antonella ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DROSPIRENONE PLUS ETHINYLESTRADIOL; FINASTERIDE; MINOXIDIL; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HAIR LOSS; HUMAN; PHOTOGRAPHY; PREMENOPAUSE; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; ALDOSTERONE ANTAGONISTS; ALOPECIA; CONTRACEPTIVES, ORAL, COMBINED; ENZYME INHIBITORS; ESTROGENS; ETHINYL ESTRADIOL; FEMALE; FINASTERIDE; HUMANS; MIDDLE AGED; PREMENOPAUSE; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 33645110044     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.142.3.298     Document Type: Article

References (21)

1. Price VH. Androgenetic alopecia in women. J Investig Dermatol Symp Proc. 2003;8:24-27.
2. Olsen EA. Female pattern hair loss. J Am Acad Dermatol. 2001;45:S70-S80.
3. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in female sex. Br J Dermatol. 1977;97:247-254.
4. Venning VA, Dawber RP. Patterned androgenetic alopecia in women. J Am Acad Dermatol. 1988;18:1073-1077.
5. Price VH, Menefee E. Quantitative estimation of hair growth, I: androgenetic alopecia in women: effect of minoxidil. J Invest Dermatol. 1990;95:683-687.
6. Dawber RPR, Sonnex T, Ralfs I. Oral antiandrogen treatment of common baldness in women [abstract]. Br J Dermatol. 1982;107(suppl 22):20.
7. Mortimer CH, Rushton H, James KC. Effective medical treatment of common baldness in women. Clin Exp Dermatol. 1984;9:342-350.
8. Peereboom-Wynia JD, van der Willigen AH, van Joost T, Stolz E. The effect of cyproterone acetate on hair roots and hair shafts diameter in androgenetic alopecia in females. Acta Derm Venereol. 1989;69:395-398.
9. Vexiau P, Chaspoux C, Boudou P, et al. Effects of minoxidil 2% vs cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial. Br J Dermatol. 2002;146:992-999.
10. Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol. 2005;152:466-473.
11. Carmina E, Lobo RA. Treatment of hyperandrogenic alopecia in women. Fertil Steril. 2003;79:91-95.
12. Camacho F. Hirsutismo: enfoque clinico terapéutico. Act Terap Dermatol. 2001;24:190-206.
13. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39:578-588.
14. de Lacharrière O, Deloche C, Misciali C, et al. Hair diameter diversity. Arch Dermatol. 2001;137:641-646.
15. Prahalada S, Tarantal AS, Harris GS, et al. Effects of finasteride, a type 2 5α-reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta). Teratology. 1997;55:119-131.
16. Price VH, Roberts JL, Hordinsky M, et al. Lack of efficacy of finasteride in post-menopausal women with androgenetic alopecia. J Am Acad Dermatol. 2000;43:768-776.
17. Thai KE, Sinclair R. Finasteride for female androgenetic alopecia. Br J Dermatol. 2002;147:812-813.
18. Shum KW, Cullen DR, Messenger AG. Hair loss in women with hyperandrogenism: four cases responding to finasteride. J Am Acad Dermatol. 2002;47:733-739.
19. Trueb RM. Finasteride treatment of patterned hair loss in normoandrogenic post-menopausal women. Dermatology. 2004;209:202-207.
20. Olszewska M, Rudnicka L. Effective treatment of female androgenic alopecia with dutasteride. J Drugs Dermatol. 2005;4:637-640.
21. Batur P, Elder J, Mayer M. Update on contraception: benefits and risks of the new formulations. Cleve Clin J Med. 2003;70:681-696.